IBC Life Sciences

The leading provider of scientific, technological and business information

Main menu

My IBC

Login form

Sign Up

AsiaTIDES: Oligonucleotide and Peptide® Research, Technology and Product Development

CSS

Event Information

Delivering the Latest Research and Best Practices from Around the World

February 22 - 24, 2010 · Sheraton Miyako Hotel · Tokyo, Japan

Alt languages

Alternate Language Options: Japanese Korean Taiwanese Chinese

Document Title

Innovation Showcase

Innovation Showcase

Wednesday, February 24, 2010 at 1:30 PM

Investment and Licensing Opportunties
Chairperson:
David Konys, Vice President, Manufacturing Operations, Alnylam Pharmaceuticals, Inc., USA

Four emerging drug development and technology companies will give 15-minute updates on their business plan, technology, and partnering objectives. For more information on how to present in the Innovation Showcase, please see guidelines listed below.


Guidelines for submitting proposals for Innovation Showcase at AsiaTIDES 2010

This is an opportunity to give a fifteen-minute presentation to major Japanese pharmaceutical companies and other attendees during the Innovation Showcase at AsiaTIDES, Wednesday, February 24, 2010, 1:30 - 2:30 pm.

Eligibility:
The Innovation Showcase is seeking presenters who are developing unique technologies and products which have not been presented at a TIDES meeting before. Your technology should be at a relatively early stage of development.

Proposal Guidelines - Deadline: December 4, 2009
Please send a proposal of a maximum of 250 words in a word document including the following information:

  1. Company overview - brief history, founding scientists, scientific advisory board members, and key IP (intellectual property).
  2. Publicly available financing information to date
  3. Technology description
  4. Your objective in presenting (examples: to identify new research collaborators or business partners, to secure additional venture financing, etc.)

Send your proposal by email to Ellen King at eking@ibcusa.com

Judging Criteria: Proposals will be judged on novelty of technology, unmet medical needs, and feasibility of commercialization.

Proposals must be received no later than December 4, 2009. However proposals will be reviewed on a first come first served basis and presentation time slots may fill up before that date.

All presenters will be notified by December 11.

Important: You must register and pay conference registration fees by January 23 in order to receive confirmation to present in the Innovation Showcase.

Related Links

TIDES: Oligonucleotide and Peptide® Technology and Product Development
April 25 - 28, 2010 · Hynes Convention Center · Boston, MA
» More information

EuroTIDES
December 2-3, 2009 · Amsterdam
» More information

Bottom menu

Copyright IBC Life Sciences, a part of Informa Life Sciences Group. | Phone: 800.390.4078 | Email: reg@ibcusa.com

Powered by Interactive Agency Janmedia Interactive, Inc.